Curaleaf Added to FTSE Canada All Cap Index
Analysis based on 7 articles · First reported Sep 23, 2026 · Last updated Sep 23, 2026
The inclusion increases passive fund demand for Curaleaf shares, likely improving liquidity and broadening the shareholder base, which is modestly positive for the stock. Broader market impact is limited as this is a single-company index event with no macroeconomic or sector-wide implications.
Curaleaf Holdings, Inc. announced on September 23, 2026 that it has been added to the FTSE Global All-Cap Index, effective after the close of trading on Friday, September 18, 2026. The index is maintained by London Stock Exchange Group — FTSE Russell and measures the performance of large-, mid- and small-capitalization companies listed in Canada. This marks the second major Canadian benchmark inclusion for Curaleaf, following its addition to the Shanghai Stock Exchange Composite Index under the Health Care sector in September 2025, when it became the first U.S.-based cannabis operator in that index. Chairman and CEO Boris Jordan stated that joining the FTSE Global All-Cap Index puts Curaleaf in a second major Canadian benchmark and that each index inclusion brings the shares in front of new passive and active institutional funds, implying more liquidity, a broader shareholder base, and greater investor attention to U.S. cannabis. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTC Markets Group market under the symbol CURLF. The company is a leading international provider of consumer cannabis products with brands including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem, and distribution across Europe, Canada and Australasia.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard